A Randomized Trial of Cholecalciferol versus Doxercalciferol for Lowering Parathyroid Hormone in Chronic Kidney Disease

Background and objectives: The optimal treatment of secondary hyperparathyroidism in chronic kidney disease (CKD) is unknown. Design, setting, participants, & measurements: We conducted a randomized, blinded, 3-month trial in vitamin D-deficient CKD stage 3 and 4 patients with parathyroid hormon...

Full description

Saved in:
Bibliographic Details
Main Authors: Moe, Sharon M., Saifullah, Akber, LaClair, Robert E., Usman, Sohail A., Yu, Zhangsheng
Format: Artigo
Language:Inglês
Published: American Society of Nephrology 2010
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC2827596/
https://ncbi.nlm.nih.gov/pubmed/20056760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.07131009
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items